203 related articles for article (PubMed ID: 10216421)
1. [Acute pancreatitis induced by drugs derived from 5-aminosalicylic acid: case report and review of the literature].
Decocq G; Gras-Champel V; Vrolant-Mille C; Delcenserie R; Sauvé L; Masson H; Andréjak M
Therapie; 1999; 54(1):41-8. PubMed ID: 10216421
[TBL] [Abstract][Full Text] [Related]
2. [Pancreatitis associated with 5-aminosalicylic acid].
Eckardt VF; Kanzler G; Rieder H; Ewe K
Dtsch Med Wochenschr; 1991 Apr; 116(14):540-2. PubMed ID: 1707359
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
4. Acute pancreatitis after long-term 5-aminosalicylic acid therapy.
Fernández J; Sala M; Panés J; Feu F; Navarro S; Terés J
Am J Gastroenterol; 1997 Dec; 92(12):2302-3. PubMed ID: 9399776
[TBL] [Abstract][Full Text] [Related]
5. [Acute pancreatitis due to 5-aminosalicylic acid].
Romero Castro R; Jiménez Sáenz M; Pellicer Bautista FJ; Domínguez Palomo S; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 1991 Mar; 79(3):219-21. PubMed ID: 2043409
[TBL] [Abstract][Full Text] [Related]
6. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Uittenbogaart SB; Klemt-Kropp M
Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
[TBL] [Abstract][Full Text] [Related]
7. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
Bayerdörffer E; Bock H
Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
Glintborg B
Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
[TBL] [Abstract][Full Text] [Related]
9. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
[TBL] [Abstract][Full Text] [Related]
10. [Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms].
Schwörer H; Ramadori G
Dtsch Med Wochenschr; 2000 Nov; 125(44):1328-30. PubMed ID: 11109415
[TBL] [Abstract][Full Text] [Related]
11. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
Faintuch J; Mott CB; Machado MC
Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
[TBL] [Abstract][Full Text] [Related]
12. [Acute pancreatitis--induced by 5-aminosalicylic acid or an extraintestinal manifestation of ulcerative colitis?].
Petersen HH; Skovbjerg H
Ugeskr Laeger; 1995 Sep; 157(39):5400-1. PubMed ID: 7483055
[TBL] [Abstract][Full Text] [Related]
13. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
14. Acute pancreatitis during oral 5-aminosalicylic acid therapy.
Fiorentini MT; Fracchia M; Galatola G; Barlotta A; de la Pierre M
Dig Dis Sci; 1990 Sep; 35(9):1180-2. PubMed ID: 2390934
[TBL] [Abstract][Full Text] [Related]
15. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
Schölmerich J
Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
[TBL] [Abstract][Full Text] [Related]
16. [Acute manifestations in Crohn disease and ulcerative colitis. Conservative treatment of acute situations].
Goebell H
Langenbecks Arch Chir; 1988; Suppl 2():77-81. PubMed ID: 2907077
[TBL] [Abstract][Full Text] [Related]
17. Pancreatitis induced by disodium azodisalicylate.
Poldermans D; van Blankenstein M
Am J Gastroenterol; 1988 May; 83(5):578-80. PubMed ID: 2452567
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity.
Bresci G; Carrai M; Venturini G; Gambardella L
Int J Tissue React; 1990; 12(4):243-6. PubMed ID: 1980911
[TBL] [Abstract][Full Text] [Related]
19. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
20. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
